BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Prognosis
15 results:

  • 1. hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.
    Duan C; Li K; Pan X; Wei Z; Xiao L
    BMC Cancer; 2023 May; 23(1):489. PubMed ID: 37259027
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Priming with HDAC Inhibitors Sensitizes ovarian cancer Cells to Treatment with Cisplatin and hsp90 Inhibitors.
    Rodrigues Moita AJ; Bandolik JJ; Hansen FK; Kurz T; Hamacher A; Kassack MU
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167494
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Stress-induced phosphoprotein 1 promotes pancreatic cancer progression through activation of the FAK/AKT/MMP signaling axis.
    Jing Y; Liang W; Liu J; Zhang L; Wei J; Zhu Y; Yang J; Ji K; Zhang Y; Huang Z
    Pathol Res Pract; 2019 Nov; 215(11):152564. PubMed ID: 31547977
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.
    Muller P; Coates PJ; Nenutil R; Trcka F; Hrstka R; Chovanec J; Brychtova V; Vojtesek B
    J Ovarian Res; 2019 Mar; 12(1):30. PubMed ID: 30917858
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo.
    Wang X; Yang R; Yuan C; An Y; Tang Q; Chen D
    Target Oncol; 2018 Aug; 13(4):481-494. PubMed ID: 29992403
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Antitumor activity of nanoliposomes encapsulating the novobiocin analog 6BrCaQ in a triple-negative breast cancer model in mice.
    Sauvage F; Fattal E; Al-Shaer W; Denis S; Brotin E; Denoyelle C; Blanc-Fournier C; Toussaint B; Messaoudi S; Alami M; Barratt G; Vergnaud-Gauduchon J
    Cancer Lett; 2018 Sep; 432():103-111. PubMed ID: 29883750
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in cancer.
    Saini J; Sharma PK
    Curr Drug Targets; 2018; 19(13):1478-1490. PubMed ID: 28831912
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples.
    Kazarian A; Blyuss O; Metodieva G; Gentry-Maharaj A; Ryan A; Kiseleva EM; Prytomanova OM; Jacobs IJ; Widschwendter M; Menon U; Timms JF
    Br J Cancer; 2017 Feb; 116(4):501-508. PubMed ID: 28081538
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. BRCA1 and hsp90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation.
    Stecklein SR; Kumaraswamy E; Behbod F; Wang W; Chaguturu V; Harlan-Williams LM; Jensen RA
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13650-5. PubMed ID: 22869732
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Placental leucine aminopeptidase (P-LAP) expression is associated with chemosensitivity in human endometrial carcinoma.
    Shibata K; Kikkawa F; Kondo C; Mizokami Y; Kajiyama H; Ino K; Nomura S; Mizutani S
    Gynecol Oncol; 2004 Nov; 95(2):307-13. PubMed ID: 15491750
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Expression and significance of heat shock protein 70, 90 in endometrial carcinomas].
    Bai XX; Chen YQ; Xin XY; Wang WD
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):38-40. PubMed ID: 15132902
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries.
    Elpek GO; Karaveli S; Simşek T; Keles N; Aksoy NH
    APMIS; 2003 Apr; 111(4):523-30. PubMed ID: 12780528
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Heat shock proteins and malignancies of the female genital tract].
    Piura B; Rabinovich A; Yavelsky V; Wolfson M
    Harefuah; 2002 Nov; 141(11):969-72, 1010, 1009. PubMed ID: 12476632
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the hsp90 inhibitor geldanamycin.
    Smith V; Hobbs S; Court W; Eccles S; Workman P; Kelland LR
    Anticancer Res; 2002; 22(4):1993-9. PubMed ID: 12174876
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein hsp90.
    Xu W; Mimnaugh E; Rosser MF; Nicchitta C; Marcu M; Yarden Y; Neckers L
    J Biol Chem; 2001 Feb; 276(5):3702-8. PubMed ID: 11071886
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.